
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£220.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£142.24
7D
3.1%
1Y
32.3%
National Atomic Company Kazatomprom JSC
Market Cap: US$7.9t
Explores for, produces, processes, markets, and sells uranium and uranium related products.
KAP
US$61.70
7D
10.6%
1Y
67.4%
Intertek Group
Market Cap: UK£7.1b
Provides quality assurance solutions to various industries in the United Kingdom, the United States, China, Australia, and internationally.
ITRK
UK£45.96
7D
-0.6%
1Y
-3.9%
Halyk Bank of Kazakhstan
Market Cap: US$8.1b
Provides corporate and retail banking services primarily in the Republic of Kazakhstan, Kyrgyzstan, Georgia, and Uzbekistan.
HSBK
US$29.55
7D
-1.3%
1Y
49.7%
Softcat
Market Cap: UK£2.8b
Operates as a value-added IT reseller and IT infrastructure solutions provider in the United Kingdom.
SCT
UK£14.00
7D
-1.2%
1Y
-4.8%
Ninety One Group
Market Cap: UK£2.0b
Operates as an independent global asset manager worldwide.
N91
UK£2.21
7D
2.0%
1Y
59.6%